You funded it! Pancreatic Cancer Research Advances
YOU FUNDED IT! Researchers at Washington University School of Medicine in St. Louis and Rush University in Chicago have found a chemical compound that promotes a vigorous immune assault against pancreatic cancer. The findings, published July 3 in Science Translational Medicine, suggest that the immune-boosting compound could potentially make resistant pancreatic cancers susceptible to immunotherapy and improve treatment options for people with the devastating disease.
These findings are associated with the SPORE grant in Pancreatic Cancer, which has been heavily supported by Pedal the Cause over the last several years and led by Pedal-funded researchers Dr. David DeNardo and Dr. William Hawkins.